ARCHIVES

NCI Advisors Discuss Cap On Center Core Grants While Broder Complains Cap Is ‘Anti-Intellectual’

This article is from The Cancer Letter archive.

Vol. 17 No. 20 | May 17, 1991

Download PDF Visit The Full Archive

Related Articles

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

July 28, 2006

1981 Budget By Funding Mechanism

June 1, 1979

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

Duke Scores Highest On NCAB Review

July 14, 1978

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012